Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Examine the World Veterinary Vaccines Market

September 10, 2008

Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue.

World Veterinary Vaccines Market

http://www.reportlinker.com/p092485/World-Veterinary-Vaccines-Market.html

This report analyzes the worldwide markets for Veterinary Vaccines in US$ Million. The specific product segments analyzed are Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, & Other Animal Vaccines). The report provides separate comprehensive analytics for the US, Europe and Rest of World. Annual forecasts are provided for the period of 2000 through 2015. The report profiles 63 companies including many key and niche players worldwide such as AVANT Immunotherapeutics, Inc., Megan Health, Inc., Bayer HealthCare AG, Fort Dodge Animal Health, Heska Corporation, Imugene Limited, Merial Animal Health Ltd., Pfizer, Inc., Embrex, Inc., Protein Sciences Corporation, Schering-Plough Corporation, Intervet International B.V. , Intervet, Inc., and Virbac Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

 VETERINARY VACCINES MCP-1129 A GLOBAL STRATEGIC BUSINESS REPORT CONTENTS I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS Study Reliability and Reporting Limitations I-1 Disclaimers I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3 Product Definitions and Scope of Study I-3 A. Companion Animal Vaccines I-3 B. Livestock Vaccines I-4 Porcine Vaccines I-4 Bovine Vaccines I-4 Poultry Vaccines I-4 Ovine Vaccines I-4 Equine Vaccines I-4 Other Animal Vaccines I-5 II. EXECUTIVE SUMMARY 1. Industry Overview & Outlook II-1 Global Animal Health Care Industry - A Brief Review II-1 Table 1: Global Animal Health Products Market by Region (2007): Percentage Share Breakdown by Value Sales for Europe, North America, Latin America and Rest of World (includes corresponding Graph/Chart) II-1 Table 2: Global Animal Health Products Market by Product Group (2007): Percentage Share Breakdown by Value sales for Parasiticides, Vaccines, Anti-Infectives, Medical Feed Additives and Other Pharmaceuticals (includes corresponding Graph/Chart) II-2 Scope of the Report II-2 Current And Future Analysis II-2 2. Market Trends & Issues II-4 Companion Animal Vaccines: Trailing on a High Growth Track II-4 OTC Market: A Potential Threat for Veterinarians II-4 Parasiticides, Systemic Agents To Drive The Market II-4 Taxonomy of Vaccines II-4 Bird Flu - The Aftermath II-4 Vaccination - Critical for Controlling Avian Influenza Virus II-5 3. Product Overview II-6 Vaccines - An Evolutionary Scan II-6 Contribution of Animal Research to Vaccine Production II-6 Veterinary Medicines- A Brief Review II-7 Preventive Medicines II-7 Therapeutic Medicines II-7 Others II-7 Veterinary Vaccines - An Essential Component of Animal Health Care II-7 What Does A Veterinary Vaccine Do? II-8 Classification of Veterinary Vaccines II-8 Companion Animal Vaccines II-8 Canine Vaccines II-8 Feline Vaccines II-10 Livestock Vaccines II-11 Bovine Vaccines II-11 Poultry Vaccines II-12 Ovine Vaccines II-12 Porcine Vaccines II-12 Equine Vaccines II-13 Aquaculture Vaccines II-13 A Tabular Analysis on Select Animal Diseases Controlled by Vaccines II-13 Vaccination and Its Reactions II-14 Veterinary Vaccines- Latest Breakthroughs II-14 Marker vaccines II-14 DNA vaccines II-14 Gene-deleted vaccines II-14 Viral-vectored vaccines II-14 4. Notes on Select Animal Diseases II-16 Brucellosis II-16 Tuberculosis II-16 Johne's disease II-16 Spirochete Associated Diseases II-16 Respiratory Disease in Goats, Sheep, and Cattle II-16 Porcine Respiratory Diseases II-17 Mastitis II-17 African Swine Fever II-17 Avian Influenza II-17 East Coast Fever II-18 Hemorrhagic Septicemia II-18 Foot-And-Mouth Disease II-18 Japanese Encephalitis II-18 Rift Valley Fever II-18 5. Product Innovations/Introductions II-19 Intervet Develops Bluetongue Vaccine II-19 Agroinsuvet Introduces New Vaccines II-19 Merial Rolls Out Vaxxitek(R) HVT+IBD Hatchery Vaccine for Poultry Industry II-19 Intervet & FLI Develop Dual Vaccine Prototype for Birds II-19 Schering-Plough Receives USDA License for its Rhusigen(TM) Erysipelas Vaccine II-19 USDA Approves Use of PreveNile(TM) Vaccine for Horses II-20 Fort Dodge Animal Health Develops Reverse Genetics Avian Vaccine II-20 Boehringer Ingelheim's Swine Vaccine Gains Approval in Australia II-20 Merial Limited Gets USDA Approval for DNA Vaccine for Melanoma in Dogs II-20 Embrex's Poultry Vaccine Inovocox Gets USDA Approval II-21 Skystar Bio-Pharmaceutical Develops Avian Influenza Vaccine II-21 USDA Grants Conditional License for Necrotic Enteritis Vaccine II-21 Fort Dodge Receives USDA License for Pyramid(R)10 II-21 USDA Licenses Use of Fort Dodge's Suvaxyn(R) PCV2 Vaccine in Pigs II-22 USDA Grants Conditional License to Pfizer's New Canine Vaccine II-22 Continuum (TM) DAP Vaccine from Intervet II-22 Lohmann Unveils Vaccine for Gumboro Disease II-23 New Vaccine for Bovine Respiratory Disease II-23 Corpoica & Limor Introduce Cattle Vaccine II-23 Chiron to Roll Out Rabies Vaccine in China II-23 Heska Launches Feline UltraNasal(TM) Vaccines II-23 Merial Unveils Two PUREVAX(R) Respiratory Vaccines II-23 6. Recent Industry Activity II-24 Bayer Inks Agreement with Juvaris II-24 Pfizer Inks Agreement with IVT II-24 Vivalis Extends Research Collaboration with Kaketsuken II-24 Merial Bags Major Australian Contract II-24 USDA Approves Intervet Vaccine II-24 Merial Pockets Ancare II-24 Heska Revises Distribution Agreement with AgriLabs II-25 Animal Health International Acquires Kane Veterinary II-25 Industrial Equity Investments Pockets Arysta LifeScience II-25 Henry Schein Acquires W&J Dunlop II-25 Tecnovax Establishes New Facility II-25 Pingtung Agricultural to Set Up an Exclusive Veterinary Park II-25 Ouro Fino To Expand Veterinary Product Suite II-26 Alpharma Acquires Yantai Jinhai II-26 Pfizer Animal Health Acquires Embrex II-26 Schering-Plough Acquires Intervet II-26 Schering-Plough Acquires Organon II-26 Intervet Sets Up New Animal Vaccine Production Facility in Boxmeer II-27 Crucell Licenses PER.C6(R) Technology to Pfizer Animal Health II-27 CVRL to Synthesize New Animal Vaccines II-27 Pfizer to Shut Down Omaha Animal Vaccine Center II-27 IGI Inc Licenses Novasomes to Novavax II-28 IPB Collaborates with Shigeta for Vaccine Production II-28 Suguna Poultry Steps into Livestock Vaccine Production Business II-28 European Medicines Agency Grants Community Authorization for Nobilis Influenza H7N1 II-28 AVANT & Pfizer Collaborate to Develop Animal Vaccines II-29 Intervet Acquires FMD Vaccine Production Facility from Bayer Healthcare II-29 CFIA Authorizes Bioniche E. Coli O157: H7 Cattle Vaccine for Field Use II-29 Hemispherx Biopharma Acquires DOGS Molecule Patent II-30 Hind Industries to Establish Animal Vaccine Formulations Plant at Patiala II-30 Cryosite and Animal Health Australia Form Partnership II-30 Hester Pharmaceuticals Plans Capacity Expansion II-30 Biovet Pvt Ltd to Set up Animal Vaccine Plant in Karnataka II-30 IPB and Shigeta Establish JV for Production of CLOSE 5.1 Vaccine II-30 IPB Shigeta Acquires Bird Flu Vaccine Rights from MedImmune II-30 Bioject Signs Three Agreements With Merial II-31 PetCARE signs US distribution agreement with Butler Animal Health Supply II-31 Poultry Vaccine to be produced in Vladimir II-31 DEFRA Against Vaccine Usage For Bird Flu II-31 Butler & Burns Complete Business Merger II-31 Ivax Completes Phoenix Scientific's Acquisition II-32 Crucell Signs Licensing Agreement with Merial II-32 Charlesbank Acquires Walco II-32 Imugene Signs an Agreement with Abic Biological II-32 Vical Licenses Core Technology to Merial II-32  Pfizer Acquires CSL's Veterinary Vaccines Business II-33 Antigenics Sells Feline Leukemia Vaccine Unit II-33 Embrex Establishes Novel In Ovo Vaccine Plant II-33 Indian Immunological Bags Order for Foot and Mouth Disease Vaccine II-33 Crucell Issues West Nile Virus Vaccine License to Pfizer II-33 Kimron Veterinary Signs a License Agreement with Crucell II-34 Akzo Constructs Manufacturing Unit in Boxmeer II-34 7. Research and Development II-35 Scientists Develop New Vaccine Against Disease Related to PCV2 II-35 Auburn University and Vaxin Researchers Develop Avian Flu Vaccine II-35 UK Researchers Develop In-Shell Vaccine for Chicks II-35 Researchers in Vietnam Decode the H5N1 Virus Gene II-36 Pittsburgh Researchers Create Avian Flu Vaccine from H5N1 Virus II-36 University of Warwick Develops Protecting Virus Method II-36 New Treatment Measure Against Ovine Salmonella & Brucellosis II-37 ICAR Develops Indigenous Bird Flu Vaccine II-37 St. Jude Develops Flu Virus Vaccine through Reverse Genetics II-37 Researchers Develop Vaccine for Swine Disease II-37 Researchers Develop Experimental Vaccine Against 1918 Influenza Virus II-38 Study Proves Effectiveness of Intradermal Vaccine Administration in Rabbits II-38 CEL-SCI's CEL-1000 Peptide Shows Adjuvant Activity II-38 Progress in Vaccine for Canine Cancer II-39 Vaccine for Avian Flu Developed II-39 Vector for DNA Vaccine Developed II-39 Bovine Herpesvirus 1 VP22Improves the Efficiency of DNA Vaccine II-39 Vaccine Against Canine Flu Underway II-40 Study on Immunity in Dogs II-40 New Sheep Vaccine in Clinical Trials II-40 Commercialization of Poultry Vaccine Underway II-41 Vaccine for B. Anthracis Developed II-41 Efficacy of E.Coli 0157 Vaccine Demonstrated II-41 Calgary-based Biotechnology Company to develop Oral Vaccinefor Cattle Against Pneumonia II-42 Vaccine for Tick-Borne Disease Underway II-42 Feline Immunodeficiency Virus Rhinotracheitis Vaccine for Cats Under Trials II-42 Japanese Study on Bird Flu Vaccine II-42 8. Focus on Select Global Players II-43 AVANT Immunotherapeutics, Inc (USA) II-43 Megan Health, Inc. (USA) II-43 Bayer HealthCare AG (Germany) II-43 Fort Dodge Animal Health (USA) II-43 Heska Corporation (USA) II-44 Imugene Limited (Australia) II-44 Merial Animal Health Ltd. (UK) II-44 Pfizer, Inc. (USA) II-45 Embrex, Inc. (USA) II-45 Protein Sciences Corporation (USA) II-45 Schering-Plough Corporation (USA) II-46 Intervet International B.V. (The Netherlands) II-46 Intervet, Inc. (USA) II-47 Virbac Corporation (USA) II-47 9. Global Market Perspective II-48 Table 3: World Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-48 Table 4: World Long-term Projections for Veterinary Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-49 Table 5: World 10-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-49 Table 6: World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-50 Table 7: World Long-term Projections for Companion Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011through 2015 (includes corresponding Graph/Chart) II-51 Table 8: World 10-Year Perspective for Companion Animal Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-51 Table 9: World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Product Segment- Canine Vaccines & Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-52 Table 10: World Long-term Projections for Companion Animal Vaccines by Product Segment- Canine Vaccines & Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-52 Table 11: World 10-Year Perspective for Companion Animal Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Canine Vaccines & Feline Vaccines Markets for Years 2003, 2008 & 2012 II-53 Table 12: World Recent Past, Current & Future Analysis for Canine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-54 Table 13: World Long-term Projections for Canine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart) II-55 Table 14: World 10 - Year Perspective for Canine Vaccines by Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-55 Table 15: World Recent Past, Current & Future Analysis for Feline Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-56 Table 16: World Long-term Projections for Feline Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart) II-57 Table 17: World 10 - Year Perspective for Feline Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-57 Table 18: World Recent Past, Current & Future Analysis for Livestock Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-58 Table 19: World Long-term Projections for Livestock Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding  Graph/Chart) II-59 Table 20: World 10 - Year Perspective for Livestock Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-59 Table 21: World Recent Past, Current & Future Analysis for Livestock Vaccines by Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-60 Table 22: World Long-term Projections for Livestock Vaccines by Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart) II-61 Table 23: World 10-Year Perspective for Livestock Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-62 Table 24: World Recent Past, Current & Future Analysis for Porcine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-63 Table 25: World Long-term Projections for Porcine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart) II-64 Table 26: World 10 - Year Perspective for Porcine Vaccines by Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-64 Table 27: World Recent Past, Current & Future Analysis for Bovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-65 Table 28: World Long-term Projections for Bovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-66 Table 29: World 10 - Year Perspective for Bovine Vaccines by Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-66 Table 30: World Recent Past, Current & Future Analysis for Poultry Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-67 Table 31: World Long-term Projections for Poultry Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-68 Table 32: World 10 - Year Perspective for Poultry Vaccines by Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-68 Table 33: World Recent Past, Current & Future Analysis for Ovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-69 Table 34: World Long-term Projections for Ovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart) II-70 Table 35: World 10 - Year Perspective for Ovine Vaccines by Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-70 Table 36: World Recent Past, Current & Future Analysis for Equine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-71 Table 37: World Long-term Projections for Equine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-72 Table 38: World 10 - Year Perspective for Equine Vaccines by Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-72 Table 39: World Recent Past, Current & Future Analysis for Other Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-73 Table 40: World Long-term Projections for Other Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart) II-74 Table 41: World 10 - Year Perspective for Other Animal Vaccines by Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-74 III. MARKET 1. The United States III-1 A.Market Analysis III-1 Current & Future Analysis III-1 H5N1 Virus: A Conundrum for the US Industry III-1 Rabies Cases in the US (2005) III-1 Historic Data III-2 Table 42: Leading Players in the US Rabies Vaccines Market (1995): Percentage Market Share for Pfizer, Fort Dodge, Solvay, Rhone Merieux and Others (includes corresponding Graph/Chart) III-2 Strategic Developments III-2 Product Launches/ Developments III-6 Key US Players III-9 AVANT Immunotherapeutics, Inc (USA) III-9 Megan Health Inc. III-9 Fort Dodge Animal Health III-9 Heska Corporation III-10 Intervet, Inc. III-10 Pfizer Inc III-10 Embrex, Inc III-11 Protein Sciences Corporation III-11 Schering-Plough Corporation III-11 Virbac Corporation III-12 B.Market Analytics III-13 Table 43: US Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-13 Table 44: US Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart) III-14 Table 45: US 10-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-15 2. Europe III-16 A.Market Analysis III-16 Current & Future Analysis III-16 By Segment III-16 Strategic Development III-16 B.Market Analytics III-17 Table 46: European Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-17 Table 47: European Long-term Projections for Veterinary Vaccines by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-18 Table 48: European 10-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, United Kingdom and Rest of Europe for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-19 Table 49: European Recent Past, Current & Future Analysis of Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-20 Table 50: European Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart) III-21 Table 51: European 10 - Year Perspective for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-22 2a. France III-23 A.Market Analysis III-23 Current & Future Analysis III-23 Strategic Development III-23 B.Market Analytics III-24 Table 52: French Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines & Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-24 Table 53: French Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, & Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-25 Table 54: French 10-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines & Equine Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-26 2b. Germany III-27 A.Market Analysis III-27 Current & Future Analysis III-27 Strategic Developments III-27 Key German Players III-28 Bayer HealthCare AG III-28 B.Market Analytics III-28 Table 55: German Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/ Segment - Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines & Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-28 Table 56: German Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, & Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-29 Table 57: German 10-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines & Equine Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-30 2c. Italy III-31 Market Analysis III-31 Table 58: Italian Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-31 Table 59: Italian Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-32 Table 60: Italian 10-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-33 2d. The United Kingdom III-34 A.Market Analysis III-34 Current & Future Analysis III-34 Strategic Corporate Developments III-34 Product Launches III-34 Key Player in UK III-35 Merial Animal Health Ltd III-35 B.Market Analytics III-36 Table 61: UK Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-36 Table 62: UK Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-37 Table 63: UK 10-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines &Other Animal Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-38 2e. Rest of Europe III-39 A.Market Analysis III-39 Overview III-39 A Note on Danish Veterinary Services III-39 The 2002 Standards of Danish Medicines recommend test for antibody inducing fragments in veterinary vaccines III-40 Hungary Vaccinates Birds Across Zoos III-40 Russia Mass-Produces Vaccines Against Avian Flu III-40 Product Launches/Developments III-41 Strategic Developments III-41 Focus on Select Players III-43 Intervet International B.V. (The Netherlands) III-43 B.Market Analytics III-44 Table 64: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Vaccines - by Product Group/ Segment for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-44 Table 65: Rest of Europe Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart) III-45 Table 66: Rest of Europe 10-Year Perspective for Veterinary Vaccines by Product/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines,  Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-46 3. Rest of World III-47 A.Market Analysis III-47 Overview III-47 Focus on Select Regions III-47 Canada III-47 Overview of Canadian Animal Health Industry III-47 Import and Manufacture of Veterinary Biologics III-47 First to Access E. coli 0157: H7 Vaccine III-48 China III-48 An Emerging Veterinary Vaccine Hub III-48  China Initiates Mass Vaccination Campaign Against Bird Flu Virus III-48 Australia III-49 A Note on Australian Veterinary Therapeutics Market III-49 India III-49 ICAR Develops Indigenous Bird Flu Vaccine III-49 Thailand III-49 Japan & Thailand to Cooperate for Developing Bird Flu Vaccine III-49 Malaysia III-49 Malaysia Initiates Measures to Deal with Potential Flu Pandemic III-49 Kazakhstan III-50 Kazakhstan Takes Proactive Measures Against Bird Flu III-50 North Korea III-50 North Korea Develops Bird Flu Vaccine III-50 Vietnam III-50 Vietnam to Mass-Produce Bird Flu Vaccines III-50 Vietnam Imports Bird Flu Vaccine from Russia III-50 Egypt III-50 Egypt Reports H5N1 Infection in Vaccinated Flocks III-50 Kenya III-50 Kenya to Mass-Manufacture Vaccines Against Rift Valley Fever III-50 Strategic Developments III-51 Product Launches/Developments III-55 Focus on Select players III-56 Immunovaccine Technologies Inc. (Canada) III-56 Imugene Limited (Australia) III-56 Indian Immunologicals Ltd (India) III-56 B.Market Analytics III-57 Table 67: Rest of World Recent Past, Current & Future Analysis for Veterinary Vaccines - by Product Group/ Segment for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-57 Table 68: Rest of World Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-58 Table 69: Rest of World 10-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-59 IV. COMPETITIVE LANDSCAPE 

To order this report:

World Veterinary Vaccines Market

http://www.reportlinker.com/p092485/World-Veterinary-Vaccines-Market.html

More market research reports here!

 Contacts: Reportlinker.com Nicolas US: (805) 652-2626 or Int: +1-805-652-2626 Email: nbo@reportlinker.com

SOURCE: Reportlinker.com